The glycosaminoglycan-binding domain of PRELP acts as a cell type–specific NF-κB inhibitor that impairs osteoclastogenesis
暂无分享,去创建一个
D. Heinegård | E. Åhrman | M. Capulli | A. Teti | N. Rucci | D. Capece | F. Zazzeroni | E. Alesse | A. Rufo | A. Del Fattore | V. Iansante | Marina Alamanou